MARGARET BIGGINS: Open Payments
NPI 1225580400 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,527 in 54 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $1,527
Food & beverage: $1,527
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $511 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $356 |
| JAZZ PHARMACEUTICALS INC. | 11 | $327 |
| Axsome Therapeutics, Inc. | 3 | $95 |
| Lilly USA, LLC | 3 | $86 |
| Verona Pharma, Inc. | 2 | $60 |
| HARMONY BIOSCIENCES LLC | 1 | $43 |
| Grifols USA, LLC | 1 | $31 |
| Electromed, Inc. | 1 | $18 |
Products named: XYWAV, GLASSIA, FASENRA, TEZSPIRE, Sunosi, ZEPBOUND, BREZTRI, Ohtuvayre.
Industry payments across DC — which companies pay providers there.
